Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560183 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain
A Phase 3 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 256
- Enrollment target
NCT00560183 is a Phase 3 study that has completed, run by QRxPharma. The registered enrollment target is 256 participants.
The verdict
NCT00560183, a Phase 3 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 256 participants
- Enrollment target
Study Summary
This study will explore the efficacy and safety of a fixed dose combination of morphine and oxycodone for management of acute postoperative pain. The study will explore the efficacy dose response and dosing interval required to maintain adequate analgesia at each tested dosage strength.
Interventions
- DRUG Placebo
- DRUG Q8003 (morphine sulfate and oxycodone hydrochloride)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560183
The ClinicalTrials.gov registry entry for NCT00560183 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QRxPharma, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00560183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560183 about?
NCT00560183 is a clinical study titled "Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain". This study will explore the efficacy and safety of a fixed dose combination of morphine and oxycodone for management of acute postoperative pain. The study will explore the efficacy dose response and dosing interval required to maintain adequate analgesia at each tested dosage strength.
What is the current status of trial NCT00560183?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 256 participants. The study started on 2007-11. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00560183?
The interventions under investigation include: Placebo (DRUG), Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG).
Who is sponsoring clinical trial NCT00560183?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.